Kevin Zhang1, Avika Misra2, Patrick J Kim3, Seyed M Moghadas4, Joanne M Langley5, Marek Smieja3,6. 1. Faculty of Medicine, University of Toronto, Toronto, ON. 2. Faculty of Medicine, University of Ottawa, Ottawa, ON. 3. Department of Medicine, McMaster University, Hamilton, ON. 4. Agent-Based Modelling Laboratory, York University, Toronto, ON. 5. Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre and Nova Scotia Health Authority, Halifax, NS. 6. St. Joseph's Healthcare Hamilton, Hamilton, ON.
Abstract
BACKGROUND: Public health measures, such as physical distancing and closure of schools and non-essential services, were rapidly implemented in Canada to interrupt the spread of the coronavirus disease 2019 (COVID-19). We sought to investigate the impact of mitigation measures during the spring wave of COVID-19 on the incidence of other laboratory-confirmed respiratory viruses in Hamilton, Ontario. METHODS: All nasopharyngeal swab specimens (n=57,503) submitted for routine respiratory virus testing at a regional laboratory serving all acute-care hospitals in Hamilton between January 2010 and June 2020 were reviewed. Testing for influenza A and B, respiratory syncytial virus, human metapneumovirus, parainfluenza I-III, adenovirus, and rhinovirus/enterovirus was done routinely using a laboratory-developed polymerase chain reaction multiplex respiratory viral panel. A Bayesian linear regression model was used to determine the trend of positivity rates of all influenza samples for the first 26 weeks of each year from 2010 to 2019. The mean positivity rate of Bayesian inference was compared with the weekly reported positivity rate of influenza samples in 2020. RESULTS: The positivity rate of influenza in 2020 diminished sharply following the population-wide implementation of COVID-19 interventions. Weeks 12-26 reported 0% positivity for influenza, with the exception of 0.1% reported in week 13. CONCLUSION: Public health measures implemented during the COVID-19 pandemic were associated with a reduced incidence of other respiratory viruses and should be considered to mitigate severe seasonal influenza and other respiratory virus pandemics.
BACKGROUND: Public health measures, such as physical distancing and closure of schools and non-essential services, were rapidly implemented in Canada to interrupt the spread of the coronavirus disease 2019 (COVID-19). We sought to investigate the impact of mitigation measures during the spring wave of COVID-19 on the incidence of other laboratory-confirmed respiratory viruses in Hamilton, Ontario. METHODS: All nasopharyngeal swab specimens (n=57,503) submitted for routine respiratory virus testing at a regional laboratory serving all acute-care hospitals in Hamilton between January 2010 and June 2020 were reviewed. Testing for influenza A and B, respiratory syncytial virus, human metapneumovirus, parainfluenza I-III, adenovirus, and rhinovirus/enterovirus was done routinely using a laboratory-developed polymerase chain reaction multiplex respiratory viral panel. A Bayesian linear regression model was used to determine the trend of positivity rates of all influenza samples for the first 26 weeks of each year from 2010 to 2019. The mean positivity rate of Bayesian inference was compared with the weekly reported positivity rate of influenza samples in 2020. RESULTS: The positivity rate of influenza in 2020 diminished sharply following the population-wide implementation of COVID-19 interventions. Weeks 12-26 reported 0% positivity for influenza, with the exception of 0.1% reported in week 13. CONCLUSION: Public health measures implemented during the COVID-19 pandemic were associated with a reduced incidence of other respiratory viruses and should be considered to mitigate severe seasonal influenza and other respiratory virus pandemics.
Entities:
Keywords:
COVID-19; Canada; influenza; public health interventions; testing
Authors: Sophie A Valkenburg; John A Rutigliano; Ali H Ellebedy; Peter C Doherty; Paul G Thomas; Katherine Kedzierska Journal: Microbes Infect Date: 2011-02-02 Impact factor: 2.700
Authors: Seyed M Moghadas; Meagan C Fitzpatrick; Pratha Sah; Abhishek Pandey; Affan Shoukat; Burton H Singer; Alison P Galvani Journal: Proc Natl Acad Sci U S A Date: 2020-07-06 Impact factor: 11.205
Authors: Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng Journal: N Engl J Med Date: 2020-01-29 Impact factor: 176.079
Authors: Kevin Zhang; Thomas N Vilches; Mehreen Tariq; Alison P Galvani; Seyed M Moghadas Journal: Int J Infect Dis Date: 2020-10-09 Impact factor: 3.623
Authors: Justin Lessler; Nicholas G Reich; Ron Brookmeyer; Trish M Perl; Kenrad E Nelson; Derek A T Cummings Journal: Lancet Infect Dis Date: 2009-05 Impact factor: 25.071
Authors: Gannon C K Mak; Stephen S Y Lau; Edman T K Lam; Ken H L Ng; Rickjason C W Chan Journal: Influenza Other Respir Viruses Date: 2022-06-01 Impact factor: 5.606
Authors: S N Surendran; R Nagulan; K Sivabalakrishnan; S Arthiyan; A Tharsan; T T P Jayadas; S Raveendran; T Kumanan; R Ramasamy Journal: BMC Public Health Date: 2022-02-24 Impact factor: 3.295